Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern (Q37091253)

18 August 2017

1 reference

title

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern (English)

1 reference

18 August 2017

0 references

0 references

1 reference

2

Kevin B Laupland

1 reference

18 August 2017

1

Johann D D Pitout

1 reference

18 August 2017

publication date

1 March 2008

1 reference

Lancet Infectious Diseases

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

159-166

1 reference

Bacterial resistance: origins, epidemiology, and impact.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

The new beta-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

The CTX-M beta-lactamase pandemic.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

CTX-M: changing the face of ESBLs in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase-producing Escherichia coli strains in the Calgary health region

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

CTX-M-type extended-spectrum beta-lactamases in Italy: molecular epidemiology of an emerging countrywide problem

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

CTX-M-type beta-lactamases affect community Escherichia coli treatment, Greece

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Molecular detection of antibiotic resistance: when and where?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Controversies about extended-spectrum and AmpC beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Detection of antimicrobial resistance by small rural hospital microbiology laboratories: comparison of survey responses with current NCCLS laboratory standards

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Performance in detection and reporting beta-lactam resistance phenotypes in Enterobacteriaceae: a nationwide proficiency study in Italian laboratories.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Evaluation of the new VITEK 2 extended-spectrum beta-lactamase (ESBL) test for rapid detection of ESBL production in Enterobacteriaceae isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Modification of the double-disk test for detection of enterobacteriaceae producing extended-spectrum and AmpC beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum beta-lactamase-producing Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Use of microdilution panels with and without beta-lactamase inhibitors as a phenotypic test for beta-lactamase production among Escherichia coli, Klebsiella spp., Enterobacter spp., Citrobacter freundii, and Serratia marcescens.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Detection of mutations conferring extended-spectrum activity on SHV beta-lactamases using polymerase chain reaction single strand conformational polymorphism (PCR-SSCP)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Rapid discriminatory detection of genes coding for SHV beta-lactamases by ligase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Discrimination of SHV beta-lactamase genes by restriction site insertion-PCR

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Molecular detection of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Genetic methods for detection of antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Phenotypic and molecular detection of CTX-M-beta-lactamases produced by Escherichia coli and Klebsiella spp

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

bla(CTX-M) genes in clinical Salmonella isolates recovered from humans in England and Wales from 1992 to 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Development and clinical validation of a molecular diagnostic assay to detect CTX-M-type beta-lactamases in Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum (beta)-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Identification of CTX-M-type extended-spectrum-beta-lactamase genes using real-time PCR and pyrosequencing

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum- -lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Evolution and clinical importance of extended-spectrum beta-lactamases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Clinical and Microbiologic Analysis of a Hospital's Extended‐Spectrum β‐Lactamase‐Producing Isolates Over a 2‐Year Period

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Bacteremia caused by Escherichia coli producing extended-spectrum beta-lactamase: a case-control study of risk factors and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

The changing epidemiology of Staphylococcus aureus?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2808%2970041-0

7 January 2021

10.1016/S1473-3099(08)70041-0

Identifiers

DOI

1 reference

18 August 2017

1 reference